PepGen Inc. (PEPG)
5.66
-0.08
(-1.39%)
USD |
NASDAQ |
Dec 12, 16:00
5.67
+0.01
(+0.18%)
After-Hours: 20:00
PepGen EPS Diluted (Quarterly): -0.5246 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Sarepta Therapeutics, Inc. | -1.795 |
| Gossamer Bio, Inc. | -0.2115 |
| Immuneering Corp. | -0.3772 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.03M |
| Total Expenses (Quarterly) | 18.03M |
| Enterprise Value | 242.89M |
| Earnings Yield | -50.11% |
| Normalized Earnings Yield | -50.11 |